Commercial Air Travel for Passengers With Cardiovascular Disease: Stressors of Flight and Aeromedical Impact.

Current Problems in Cardiology
Choong Hou Koh

Abstract

The exponential growth of commercial flights has resulted in a sharp rise of air travellers over the last 2 decades, including passengers with a wide range of cardiovascular conditions. Notwithstanding the ongoing COVID-19 pandemic that had set back the aviation industry for the next 1 to 2 years, air travel is expected to rebound fully by 2023-2024. Guidelines and evidence-based recommendations for safe air travel in this group vary, and physicians often encounter situations where opinions and assessments on fitness for flights are sought. This article aims to provide an overview of the stressors of commercial passenger flights with an impact on cardiovascular health for the general cardiologist and family practitioner, when assessing the suitability of such patients for flying fitness.

References

Oct 1, 1992·International Journal of Sports Medicine·G Le RouxJ P Richalet
Oct 1, 1988·Pacing and Clinical Electrophysiology : PACE·Y CoppermanS Laniado
Sep 1, 1989·Annals of Internal Medicine·T A DillardW J Mehm
May 1, 1973·Chest·R LuglianiK Wasserman
Mar 1, 1980·Circulation·D D Heistad, F M Abboud
Nov 5, 1998·The New England Journal of Medicine·P A SantucciS L Pinski
Aug 24, 1999·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·M VeglioO Pecchio
May 3, 2000·British Journal of Clinical Pharmacology·P LusardiR Fogari
May 4, 2000·Pacing and Clinical Electrophysiology : PACE·D WeilenmannR Candinas
Aug 10, 2000·Journal of the American College of Cardiology·P A CarsonM Packer
Apr 11, 2001·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·P A KaufmannA Buck
Mar 15, 2003·Occupational Medicine·Anders Knutsson
Apr 2, 2003·The American Journal of Cardiology·Frédéric RocheJean-Claude Barthélémy
Apr 26, 2003·European Heart Journal·P C Strike, A Steptoe
Jun 12, 2003·Journal of the American College of Cardiology·Christof KolbClaus Schmitt
Aug 27, 2003·Circulation·Christophe A WyssPhilipp A Kaufmann
Oct 3, 2003·Journal of Thrombosis and Haemostasis : JTH·P D HodkinsonJ Ernsting
Jul 21, 2004·Annals of Internal Medicine·Stephen E Possick, Michèle Barry
Dec 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kun HuSteven A Shea
Apr 12, 2005·Anaesthesia·S HumphreysJ P H Fee
Aug 23, 2005·Emergency Medicine Journal : EMJ·A Qureshi, K M Porter
Mar 15, 2006·Lancet·A J M SchreijerF R Rosendaal
May 22, 2007·Antioxidants & Redox Signaling·Mark R Nicolls, Norbert F Voelkel
Nov 7, 2007·Circulation·Peter Bärtsch, J Simon R Gibbs
Nov 16, 2007·Heart·Michael Joy
Dec 20, 2007·Cardiology in Review·Lakshminarayan Yerra, Pratap C Reddy
Jan 16, 2008·The American Journal of the Medical Sciences·Lawrence C Mohr
Apr 25, 2008·Cardiology·D R WoodsP R Roberts
Jun 24, 2008·Expert Review of Cardiovascular Therapy·Katia Dyrda, Paul Khairy
Jan 22, 2009·Critical Care : the Official Journal of the Critical Care Forum·Michael SandBenno Mann
Feb 24, 2009·Lancet·Danielle Silverman, Mark Gendreau
Mar 18, 2009·Critical Care : the Official Journal of the Critical Care Forum·Keith J Ruskin
Jan 25, 2011·International Journal of Cardiology·Lee IngleJohn G F Cleland
Oct 4, 2011·Thorax·S AhmedzaiUNKNOWN British Thoracic Society Standards of Care Committee
Dec 27, 2011·Aviation, Space, and Environmental Medicine·Paul H MahonyRobin F Griffiths
Dec 22, 2012·The European Respiratory Journal·Valentina A RossiMalcolm Kohler
Jan 12, 2013·Aviation, Space, and Environmental Medicine·Neil B HampsonAnthony J Gerbino
May 31, 2013·The New England Journal of Medicine·Drew C PetersonDonald M Yealy
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
May 31, 2014·European Heart Journal·Vojtech MelenovskyBarry A Borlaug

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.